Drgt Is A Specialty Pharmaceutical Company Dedicated To The Development And Commercialization Of High Value Proprietary Drugs That Deliver Measurable And Meaningful Improvements In Clinical Utility Drgt Utilizes Its Proprietary Super Api Drug Development Platform To Carefully Select And Screen Drugs And Develop Their Super Api Compositionsthe Company S Super Api Portfolio Contains 30 Compounds In Indications Such As Oncologypain And Erectile Dysfunction With Multi $ Billion Potentialsuper Api Drugs Are Protected By Global Composition Of Matter Ip Drgt Is Incorporated In Ireland With R&D Facilities In Budapesthungary
